Bonk (NASDAQ:BNKK) Lowered to “Sell” Rating by Wall Street Zen

Bonk (NASDAQ:BNKKGet Free Report) was downgraded by research analysts at Wall Street Zen from a “hold” rating to a “sell” rating in a report issued on Saturday.

Separately, Weiss Ratings lowered shares of Bonk from a “sell (d-)” rating to a “sell (e+)” rating in a research note on Wednesday, April 29th. One equities research analyst has rated the stock with a Sell rating, Based on data from MarketBeat, Bonk presently has a consensus rating of “Sell”.

View Our Latest Report on BNKK

Bonk Stock Up 9.7%

Shares of NASDAQ:BNKK opened at $1.93 on Friday. The firm has a fifty day moving average of $2.43 and a two-hundred day moving average of $3.56. The firm has a market capitalization of $15.44 million, a P/E ratio of -0.42 and a beta of 1.97. Bonk has a 12-month low of $1.53 and a 12-month high of $46.90.

Bonk (NASDAQ:BNKKGet Free Report) last issued its earnings results on Wednesday, May 13th. The company reported ($0.23) earnings per share (EPS) for the quarter. The company had revenue of $0.79 million for the quarter. Bonk had a negative net margin of 838.37% and a negative return on equity of 148.62%.

Insider Activity

In other Bonk news, Director Mitchell Austin Rudy acquired 31,055 shares of Bonk stock in a transaction that occurred on Thursday, April 9th. The stock was acquired at an average price of $2.82 per share, with a total value of $87,575.10. Following the purchase, the director owned 44,198 shares in the company, valued at approximately $124,638.36. This trade represents a 236.29% increase in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Insiders own 51.60% of the company’s stock.

Institutional Investors Weigh In On Bonk

Several institutional investors and hedge funds have recently modified their holdings of the business. State Street Corp acquired a new stake in shares of Bonk in the 4th quarter valued at $33,000. Steward Partners Investment Advisory LLC acquired a new stake in shares of Bonk in the 4th quarter valued at $37,000. Jane Street Group LLC acquired a new stake in shares of Bonk in the 4th quarter valued at $96,000. Finally, Geode Capital Management LLC acquired a new stake in shares of Bonk in the 4th quarter valued at $128,000. Institutional investors and hedge funds own 12.55% of the company’s stock.

Bonk Company Profile

(Get Free Report)

Safety Shot, Inc, a wellness and functional beverage company, engages in the research and development of over-the-counter products and intellectual property. Its products pipeline includes Photocil to address psoriasis and vitiligo; JW-700 to treat hair loss; JW-500 for women’s sexual wellness; NoStingz, a jellyfish sting prevention sunscreen; and JW-110 for the treatment of atopic dermatitis/eczema. The company primarily sell its products through third-party physical retail stores and partners. The company was formerly known as Jupiter Wellness, Inc and changed its name to Safety Shot, Inc in September 2023.

Featured Stories

Receive News & Ratings for Bonk Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Bonk and related companies with MarketBeat.com's FREE daily email newsletter.